Form 4: GoodRx Holdings Director Scott Wagner Gifts Shares to Family Trusts

Sentiment:

SEC Form 4 Filing


Director Scott Wagner of GoodRx Holdings, Inc. reports gifting shares of Class A Common Stock to family trusts for estate planning purposes on March 13, 2025.

Summary

  • On March 13, 2025, Scott Wagner, a director at GoodRx Holdings, Inc., gifted shares of Class A Common Stock to several family trusts.
  • He gifted 64,232 shares each to the Charles W. Wagner 2012 Irrevocable Trust, the Drew S. Wagner 2012 Irrevocable Trust, and the Avery J. Wagner 2012 Irrevocable Trust.
  • These gifts were made for estate planning purposes.
  • Following these transactions, Wagner no longer has investment control or pecuniary interest in the transferred shares.
  • Wagner also indirectly owns 182,900 shares through the Wagner Family Trust, where he and his spouse serve as trustees and his family members are beneficiaries.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transfers for estate planning purposes. It doesn't inherently convey positive or negative sentiment regarding the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions and doesn't necessarily reflect a change in the company's outlook or performance. It is common for executives to manage their personal finances through estate planning activities.

Stakeholder Impact

  • The stock gifts have minimal direct impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

DateDescription
03/13/2025Date of the stock gifts to family trusts
03/14/2025Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.